vs
Compass, Inc.（COMP）与福泰制药（VRTX）财务数据对比。点击上方公司名可切换其他公司
福泰制药的季度营收约是Compass, Inc.的1.9倍（$3.2B vs $1.7B），福泰制药净利率更高（37.3% vs -2.5%，领先39.8%），Compass, Inc.同比增速更快（23.1% vs 9.5%），福泰制药自由现金流更多（$348.6M vs $42.2M），过去两年Compass, Inc.的营收复合增速更高（27.0% vs 8.9%）
Compass, Inc.是美国主营住宅房产经纪业务的企业，其平台旗下有约3.3万名经纪人，大多为独立合同工，运营Compass、21世纪不动产、科威国际不动产、苏富比国际地产、佳士得国际地产等多个知名房产经纪品牌。
福泰制药是总部位于美国马萨诸塞州波士顿的生物制药企业，是全球首批明确采用理性药物设计策略、而非组合化学方法开发药物的生物技术公司之一。除波士顿总部外，公司还在加州圣迭戈、英国牛津郡米尔顿公园设有三处研发中心。
COMP vs VRTX — 直观对比
营收规模更大
VRTX
是对方的1.9倍
$1.7B
营收增速更快
COMP
高出13.6%
9.5%
净利率更高
VRTX
高出39.8%
-2.5%
自由现金流更多
VRTX
多$306.4M
$42.2M
两年增速更快
COMP
近两年复合增速
8.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.7B | $3.2B |
| 净利润 | $-42.6M | $1.2B |
| 毛利率 | — | 85.4% |
| 营业利润率 | -2.5% | 37.8% |
| 净利率 | -2.5% | 37.3% |
| 营收同比 | 23.1% | 9.5% |
| 净利润同比 | -5.2% | 30.5% |
| 每股收益（稀释后） | $-0.07 | $4.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COMPVRTX
| Q4 25 | $1.7B | $3.2B | ||
| Q3 25 | $1.8B | $3.1B | ||
| Q2 25 | $2.1B | $3.0B | ||
| Q1 25 | $1.4B | $2.8B | ||
| Q4 24 | $1.4B | $2.9B | ||
| Q3 24 | $1.5B | $2.8B | ||
| Q2 24 | $1.7B | $2.6B | ||
| Q1 24 | $1.1B | $2.7B |
净利润COMPVRTX
| Q4 25 | $-42.6M | $1.2B | ||
| Q3 25 | $-4.6M | $1.1B | ||
| Q2 25 | $39.4M | $1.0B | ||
| Q1 25 | $-50.7M | $646.3M | ||
| Q4 24 | $-40.5M | $913.0M | ||
| Q3 24 | $-1.7M | $1.0B | ||
| Q2 24 | $20.7M | $-3.6B | ||
| Q1 24 | $-132.9M | $1.1B |
毛利率COMPVRTX
| Q4 25 | — | 85.4% | ||
| Q3 25 | — | 86.5% | ||
| Q2 25 | — | 86.3% | ||
| Q1 25 | — | 86.9% | ||
| Q4 24 | — | 85.5% | ||
| Q3 24 | — | 85.8% | ||
| Q2 24 | — | 85.9% | ||
| Q1 24 | — | 87.3% |
营业利润率COMPVRTX
| Q4 25 | -2.5% | 37.8% | ||
| Q3 25 | -0.4% | 38.6% | ||
| Q2 25 | 1.9% | 38.8% | ||
| Q1 25 | -4.0% | 22.7% | ||
| Q4 24 | -2.9% | 35.2% | ||
| Q3 24 | -0.2% | 40.3% | ||
| Q2 24 | 1.3% | -132.9% | ||
| Q1 24 | -12.5% | 42.4% |
净利率COMPVRTX
| Q4 25 | -2.5% | 37.3% | ||
| Q3 25 | -0.2% | 35.2% | ||
| Q2 25 | 1.9% | 34.8% | ||
| Q1 25 | -3.7% | 23.3% | ||
| Q4 24 | -2.9% | 31.4% | ||
| Q3 24 | -0.1% | 37.7% | ||
| Q2 24 | 1.2% | -135.8% | ||
| Q1 24 | -12.6% | 40.9% |
每股收益（稀释后）COMPVRTX
| Q4 25 | $-0.07 | $4.64 | ||
| Q3 25 | $-0.01 | $4.20 | ||
| Q2 25 | $0.07 | $3.99 | ||
| Q1 25 | $-0.09 | $2.49 | ||
| Q4 24 | $-0.08 | $3.62 | ||
| Q3 24 | $0.00 | $4.01 | ||
| Q2 24 | $0.04 | $-13.92 | ||
| Q1 24 | $-0.27 | $4.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $199.0M | $6.6B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $782.0M | $18.7B |
| 总资产 | $1.5B | $25.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资COMPVRTX
| Q4 25 | $199.0M | $6.6B | ||
| Q3 25 | $170.3M | $6.3B | ||
| Q2 25 | $177.3M | $6.4B | ||
| Q1 25 | $127.0M | $6.2B | ||
| Q4 24 | $223.8M | $6.1B | ||
| Q3 24 | $211.2M | $6.5B | ||
| Q2 24 | $185.8M | $5.8B | ||
| Q1 24 | $165.9M | $10.2B |
股东权益COMPVRTX
| Q4 25 | $782.0M | $18.7B | ||
| Q3 25 | $773.3M | $17.3B | ||
| Q2 25 | $719.9M | $17.2B | ||
| Q1 25 | $635.0M | $16.5B | ||
| Q4 24 | $409.4M | $16.4B | ||
| Q3 24 | $428.0M | $15.6B | ||
| Q2 24 | $398.4M | $14.8B | ||
| Q1 24 | $330.3M | $18.5B |
总资产COMPVRTX
| Q4 25 | $1.5B | $25.6B | ||
| Q3 25 | $1.6B | $24.9B | ||
| Q2 25 | $1.6B | $24.0B | ||
| Q1 25 | $1.5B | $22.9B | ||
| Q4 24 | $1.2B | $22.5B | ||
| Q3 24 | $1.2B | $22.2B | ||
| Q2 24 | $1.2B | $20.1B | ||
| Q1 24 | $1.1B | $23.9B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.3M | $498.0M |
| 自由现金流经营现金流 - 资本支出 | $42.2M | $348.6M |
| 自由现金流率自由现金流/营收 | 2.5% | 10.9% |
| 资本支出强度资本支出/营收 | 0.2% | 4.7% |
| 现金转化率经营现金流/净利润 | — | 0.42× |
| 过去12个月自由现金流最近4个季度 | $203.3M | $3.2B |
8季度趋势，按日历期对齐
经营现金流COMPVRTX
| Q4 25 | $45.3M | $498.0M | ||
| Q3 25 | $75.5M | $1.2B | ||
| Q2 25 | $72.8M | $1.1B | ||
| Q1 25 | $23.1M | $818.9M | ||
| Q4 24 | $30.5M | $584.6M | ||
| Q3 24 | $37.4M | $1.4B | ||
| Q2 24 | $45.0M | $-3.8B | ||
| Q1 24 | $8.6M | $1.3B |
自由现金流COMPVRTX
| Q4 25 | $42.2M | $348.6M | ||
| Q3 25 | $73.6M | $1.1B | ||
| Q2 25 | $68.0M | $927.4M | ||
| Q1 25 | $19.5M | $778.2M | ||
| Q4 24 | $26.7M | $492.0M | ||
| Q3 24 | $32.8M | $1.3B | ||
| Q2 24 | $40.4M | $-3.8B | ||
| Q1 24 | $5.9M | $1.2B |
自由现金流率COMPVRTX
| Q4 25 | 2.5% | 10.9% | ||
| Q3 25 | 4.0% | 37.0% | ||
| Q2 25 | 3.3% | 31.3% | ||
| Q1 25 | 1.4% | 28.1% | ||
| Q4 24 | 1.9% | 16.9% | ||
| Q3 24 | 2.2% | 47.0% | ||
| Q2 24 | 2.4% | -144.5% | ||
| Q1 24 | 0.6% | 46.0% |
资本支出强度COMPVRTX
| Q4 25 | 0.2% | 4.7% | ||
| Q3 25 | 0.1% | 3.3% | ||
| Q2 25 | 0.2% | 4.9% | ||
| Q1 25 | 0.3% | 1.5% | ||
| Q4 24 | 0.3% | 3.2% | ||
| Q3 24 | 0.3% | 2.4% | ||
| Q2 24 | 0.3% | 2.6% | ||
| Q1 24 | 0.3% | 2.5% |
现金转化率COMPVRTX
| Q4 25 | — | 0.42× | ||
| Q3 25 | — | 1.15× | ||
| Q2 25 | 1.85× | 1.04× | ||
| Q1 25 | — | 1.27× | ||
| Q4 24 | — | 0.64× | ||
| Q3 24 | — | 1.31× | ||
| Q2 24 | 2.17× | — | ||
| Q1 24 | — | 1.19× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COMP
暂无分部数据
VRTX
| TRIKAFTAKAFTRIO | $2.6B | 81% |
| ALYFTREK | $380.1M | 12% |
| Manufactured Product Other | $237.4M | 7% |
